Ms. B is a 56-year-old woman who comes to your office because her skin and eyes have been yellow for the past 2 weeks.
|What is the differential diagnosis of jaundice? How would you frame the differential?|
The differential diagnosis of jaundice, or hyperbilirubinemia, is often organized pathophysiologically. It is helpful to review some basic physiology first.
Oxidation of the heme moiety of Hgb generates biliverdin, which is metabolized into unconjugated bilirubin, and then bound to albumin.
There are 3 steps in bilirubin metabolism in the liver:
Uptake: The unconjugated bilirubin-albumin complex reaches the liver cell, bilirubin dissociates, and then enters the hepatocyte.
Conjugation: Unconjugated bilirubin and glucuronic acid combine to make conjugated bilirubin.
Excretion: The hepatocyte excretes conjugated bilirubin into the bile.
The rate-limiting step of bilirubin metabolism in the liver
If excretion is impaired, conjugated bilirubin travels back through the sinusoidal membrane of the hepatocyte into the bloodstream.
Conjugated bilirubin in the bile is transported through the biliary ducts into the duodenum; it is not reabsorbed by the intestine.
Can be excreted unchanged in the stool
Can be converted to urobilinogen by colonic bacteria
Urobilinogen can be reabsorbed, entering the portal circulation.
Some is taken up by the liver and re-excreted into the bile.
Some bypasses the liver and is excreted by the kidney, thus appearing in the urine in small amounts.
Unconjugated bilirubin is not found in the urine because it is bound to albumin and cannot be filtered by the glomeruli.
Conjugated bilirubin is filtered and excreted in the urine when there is hyperbilirubinemia.
|Light stools, often described as “clay colored,” occur when extrahepatic obstruction prevents bilirubin from entering the intestine.|
If there is unconjugated hyperbilirubinemia (when > 80% of the bilirubin is unconjugated), use a pathophysiologic framework:
Increased bilirubin production
Extravasation of blood into tissues
Impaired hepatic bilirubin uptake
Drugs (rifampin, probenecid, chloramphenicol)
Impaired bilirubin conjugation (decreased hepatic glucuronosyltransferase activity)
Liver disease (causes mixed hyperbilirubinemia; usually predominantly conjugated)
Although many sources organize the differential diagnosis for conjugated hyperbilirubinemia (when > 50% is conjugated) using a pathophysiologic framework, a more practical, clinical approach uses the results of other liver function tests:
Normal liver enzymes (ALT [SGPT], ...
Log In to View More
If you don't have a subscription, please view our individual subscription options below to find out how you can gain access to this content.
Want remote access to your institution's subscription?
Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.
If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
AccessMedicine Full Site: One-Year Subscription
Connect to the full suite of AccessMedicine content and resources including more than 250 examination and procedural videos, patient safety modules, an extensive drug database, Q&A, Case Files, and more.
Pay Per View: Timed Access to all of AccessMedicine
24 Hour Subscription $34.95
48 Hour Subscription $54.95
Pop-up div Successfully Displayed
This div only appears when the trigger link is hovered over.
Otherwise it is hidden from view.